Latest Georgetown University Medical Center Stories
Could some women who naturally produce excess aromatase in their breasts have an increased risk of developing breast cancer?
Devices marketed as "electronic cigarettes" are in reality crude drug delivery systems for refined nicotine, posing unknown risks with little new benefits to smokers, according to tobacco control experts.
WASHINGTON, July 20, 2011 /PRNewswire-USNewswire/ -- Devices marketed as "electronic cigarettes" are in reality crude drug delivery systems for refined nicotine, posing unknown risks with little new benefits to smokers, according to tobacco control experts. (Logo: http://photos.prnewswire.com/prnh/20101101/DC86294LOGO) In a "Perspective" published today in the New England Journal of Medicine, researchers from the Legacy's Steven A.
MILFORD, Mass., July 7, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today welcomed the metabolomics program at Georgetown University Medical Center (GUMC) into its Centers of Innovation Program and recognized Albert J.
The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer.
WASHINGTON, June 3, 2011 /PRNewswire-USNewswire/ -- Living with type I diabetes can be challenging for young children and teenagers who have to constantly monitor their blood glucose levels and take insulin several times a day.
Georgetown University Medical Center's Howard J. Federoff, MD, PhD, joins preeminent scientists from academia, government, and industry along with advocates, at the "One Mind for Research Forum," a three-day conference designed to dramatically advance the understanding and treatment of brain disorders.
WASHINGTON, May 20, 2011 /PRNewswire-USNewswire/ -- The 2011 commencement speaker for Georgetown University's School of Medicine will be alumnus, Barbara Alving, M.D., MACP, director of the National Center for Research Resources at the National Institutes of Health (NIH).
A new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed.
A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading.